Invited Speakers & Topics
for Bioactive Materials, Consumer & Diversified Products, Veterinary, and Industrial Sessions

BIOACTIVE MATERIALS
CRS Education is Generously Sponsored by Allergan, Inc.

Advances in Colloidal Drug Delivery

Ick Chan Kwon, Korean Institute of Science and Technology, South Korea;
Theragnostic Imaging of Tumors by Delivery Carriers

Advances in Ocular Delivery

Arto Urtti, University of Helsinki, Finland
Drug Transport in Retinal Pigment Epithelium – Key Player in the Blood – Retina - Barrier

Advances in Peptide & Protein Delivery

Edith Mathiowitz, Brown University, U.S.A.

Advances in Polymer Micelles

Glen S. Kwon, University of Wisconsin, U.S.A.

Advances in Transdermal Delivery

Joke A. Bouwstra, Leiden University, The Netherlands
Transdermal Drug Delivery: State of the Art and Future Challenges

Advances in Vaccine Delivery-
Generously Sponsored by Novartis Vaccines & Diagnostics

Yvonne Perrie, Aston University, U.K.
New Vaccines for Old Diseases – What is the Best Formula?

Biodegradable/Biocompatible Polymers

Avi Domb, Hebrew University of Jerusalem, Israel Biodegradable Polymers for Cancer Therapy

Biological Responses to Nanomaterials

Kam Leong, Duke University, U.S.A.;
Delivering Biochemical and Topographical Signals from Continuous Nanostructures;
and Andre Nel, University of California-Los Angeles, U.S.A.;
and Nicola Tirreli, University of Manchester, U.K.;
Thermally Sensitive, Amphiphilic Cross-linked Nanoparticles

Biomaterials & Biointerfaces

Jennifer West, Rice University, U.S.A.

Cellular Barriers

Arwyn T. Jones, Cardiff University, U.K.;
Understanding Endocytic Pathways Towards Improved Intracellular Delivery and Targeting of Therapeutic Macromolecules;
and William M. Pardridge, University of California-Los Angeles, U.S.A.;
Blood-Brain Barrier Delivery with Molecular Trojan Horses

Imaging & Delivery in Clinical Settings

Valery Alakhov, Supratek Pharma Inc., Canada
SP1049C, A Polymer Based Anthracycline; Pivotal Phase III Program in Upper GI Cancers

Injectable Depot System

Kirk Fowers, Protherics, SLC, U.S.A.
Drug Delivery for Local Tumor Management: OncoGel Clinical Experience

Nanoencapsulation-
Generously Sponsored by Novartis Pharmaceuticals Corporation – Pharmaceutical & Analytical Development - US

Jean-Pierre Benoit, INSERM, France
&
Rainer Mueller, Pharmasol GmbH, Germany Oral Drug Nanocrystals of Poorly Soluble Drugs : Present State and Development Trends

Nanotechnology-Bioactive Materials and Consumer Diversified Products/joint session

New Polymers for Drug Delivery

Nobuhiko Yui, Japan Advanced Institute of Science and Technology, Japan
Supramolecular Polyrotaxanes for Drug Delivery

Nonviral Gene Delivery

Muthiah Manoharan, Alnylam Pharmaceuticals, U.S.A.
Non-Viral Delivery of Chemically Modified siRNA Drugs

Oral Delivery-
Generously sponsored by Degussa

Young Ro Byun, Seoul National University, South Korea
Nanostructured Heparin Derivatives for Oral Delivery

Polymer Conjugates

Blanka Rihova, Institute of Microbiology ASCR, Czech Republic
The Relationship Between the Structure of a Non-targeted Polymeric Drug and Its Accumulation and Intracellular Trafficking

Pulmonary Delivery

Peter Byron, Virginia Commonwealth University, U.S.A.

Targeted Delivery

Paul J. Carter, Seattle Genetics, Inc., U.S.A.;
Antibody-Drug Conjugates for Cancer Therapy: From Target Selection to Conjugate Optimization;
and Vladimir P. Torchilin, Northeastern University, U.S.A.;
Overcoming MDR: Drug Delivery Systems Modified with Monoclonal Antibodies and/or Cell-penetrating Peptides

Tumor Targeting

Tamara Minko, Rutgers University, U.S.A.
Tumor-Specific Targeting of Drug Delivery Systems for Cancer Therapy and Imaging

CONSUMER & DIVERSIFIED PRODUCTS-
C&DP Education is Generously Sponsored by Coating Place, Inc.

Advances in Process Technology

Richard Timmons, University of Texas-Arlington, U.S.A.

Controlled Release in Food

Roger Parker, Institute of Food Research, U.K.
Formation and Stability of Biopolyelectrolyte Multilayers and Their Potential Use for the Encapsulatino and Controlled Release of Active Ingredients From Foods

Controlled Release in Health and Wellness

Yoav Blatt, LycoRed Bio, Israel
Microencapsulation as a Tool for Food Fortification

Innovative Materials and Release Mechanisms

Helmut Viernstein, University of Vienna, Austria

Nanotechnology-Consumer and Diversified Products/Bioactive Materials joint session

Marlene Bourne, Bourne Research LLC, U.S.A.
&
Molly Stevens, Imperial College, U.K.

Personal Care and Household Care

Bozena Michniak-Kohn, Rutgers University, U.S.A.
Controlled Release of Actives in Skin

VETERINARY

Emerging Role of Alternative Delivery in Veterinary Medicine-
Generously Sponsored by Novartis Animal Health US, Inc.

Katrina Mealey, Washington State University, U.S.A.
Pharmacogenetics in Veterinary Medicine

INDUSTRIAL SESSION
Generously Sponsored by Pfizer

Co-chairs: Susan Cady, Intervet, Inc., U.S.A.; and David Friend, U.S.A.
The year’s meeting will feature a two-day industrial session. Come hear the experts discuss regulatory issues, preparing for liquidity events, project management, biodegradable polymers, an industrial perspective on design and selection of extended release dosage forms, an industrial perspective on quality by design, the interface between intellectual property rights and the legal framework of pharmaceutical regulatory process, challenges in product development, and much more. Some of the Industrial Session Invited Speakers will be:

George Baskinger, Vyteris, Inc., U.S.A.
Regulatory Issues in Obtaining Approval of Drug-device Combination Products

Debra Bingham, Valeo Partners, U.S.A.
Preparing for Liquidity Events

Laura Bix, Michigan State University, U.S.A.
Packaging of Drug-device Combination Product

Diane Burgess, University of Connecticut, U.S.A.
IV-IVC

David Friend, U.S.A.
Development of Drug-device Controlled Release Products

John Gibson, Durect Corporation, U.S.A.
Biodegradable Polyesters as Excipients for Controlled Release Products

Ian Hardy, Merck Sharp & Dohme, U.K.
Design and Selection of Extended Release Dosage Forms - An Industrial Perspective

Nirdosh Jagota, Wyeth Research, U.S.A.
Quality by Design: Industry Perspective

Anne-Marie Lademann, Lifiecycle Pharma, Denmark
The Interface Between Intellectual Property Rights and the Legal Framework of the Pharmaceutical Regulatory Process

Franklin Okumu, Durect Corporation, U.S.A.
Protein Formulation for Injectable Drug Delivery Systems

John Patton, Inhale Therapeutic Systems, U.S.A.
Challenges in Inhalation Product Development

Avinash G. Thombre, Pfizer, Inc., U.S.A.
Oral Controlled Release Product Scale-up

Vladimir P. Torchilin, Northeastern University, U.S.A.
Nanotechnology